Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
Open Access
- 15 April 2019
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 93 (8)
Abstract
HIV-1 persists as a latent infection in CD4 + T cells that can be found in lymphoid tissues in infected individuals during ART. However, the importance of this tissue reservoir and its contribution to viral rebound upon ART interruption are not clear. In this study, we sought to compare latent HIV-1 from blood and lymph node CD4 + T cells from five HIV-1-infected individuals. Further, we analyzed the contribution of lymph node viruses to viral rebound. We observed that the frequencies of intact proviruses were the same in blood and lymph node. Moreover, expanded clones of T cells bearing identical proviruses were found in blood and lymph node. These latent reservoir sequences did not appear to be the direct origin of rebound virus. Instead, latent proviruses were found to contribute to the rebound compartment by recombination.Keywords
All Related Versions
Funding Information
- Danish Council for Independent Research (6110-00163)
- The Bill and Melinda Gates Foundation for AIDS Vaccine Discovery (OPP1092074, OPP1124068)
- National Institute of Health (1UM1-AI100663, R01AI-129795)
- Einstein-Rockefeller-CUNY Center for AIDS Research (1P30AI124414-01A1)
- BEAT-HIV Delaney Grant (UM1 AI126620)
- Robertson Fund
- HHS | NIH | National Institute of Allergy and Infectious Diseases (K23AI136578)
- Aarhus Universitet
This publication has 42 references indexed in Scilit:
- Relationship between intact HIV-1 proviruses in circulating CD4 + T cells and rebound viruses emerging during treatment interruptionProceedings of the National Academy of Sciences, 2018
- Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trialThe Lancet HIV, 2016
- Defective proviruses rapidly accumulate during acute HIV-1 infectionNature Medicine, 2016
- HIV-1 Reservoirs During Suppressive TherapyTrends in Microbiology, 2016
- HIV-1 Integration Landscape during Latent and Active InfectionCell, 2015
- Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 CureCell, 2013
- Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cellsNature Medicine, 2003
- Re-emergence of HIV after stopping therapyNature, 1999
- Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapyNature Medicine, 1999
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997